Back
Medpace Holdings Quote, Financials, Valuation and Earnings
Sponsored
MEDP
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Buy
68
MEDP
Medpace Holdings
Last Price:
395.88
Seasonality Move:
14.22%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.Medpace Holdings Price Quote
$395.88
-0.05 (1.57%)
(Updated: April 27, 2024 at 6:12 AM ET)
Medpace Holdings Key Stats
Buy
68
Medpace Holdings (MEDP)
is a Buy
Day range:
$388.88 - $397.17
52-week range:
$195.03 - $421.00
Dividend yield:
0%
P/E ratio:
44.59
P/S ratio:
6.41
P/B ratio:
18.27%
Volume:
144.6K
Avg. volume:
237.7K
1-year change:
94.15%
Market cap:
$12.3B
Revenue:
$1.9B
EPS:
$9.81
How Much Does Medpace Holdings Make?
-
How Much Are Medpace Holdings's Sales Annually?
MEDP Revenues are $1.9B -
How Much Profit Does Medpace Holdings's Make A Year?
MEDP net income is $282.8M
Is Medpace Holdings Growing As A Company?
-
What Is Medpace Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.18% -
What Is Medpace Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.41%
Medpace Holdings Stock Price Performance
-
Did Medpace Holdings Stock Go Up Last Month?
Medpace Holdings share price went down by -1.69% last month -
Did MEDP's Share Price Rise Over The Last Year?
MEDP share price rose by 94.15% over the past 1 year
What Is Medpace Holdings 52-Week High & Low?
-
What Is Medpace Holdings’s 52-Week High Share Price?
Medpace Holdings has traded as high as $421.00 over the past 52 weeks -
What Is Medpace Holdings’s 52-Week Low Share Price?
Medpace Holdings has traded as low as $195.03 over the past 52 weeks
Medpace Holdings Price To Free Cash Flow
-
Is Medpace Holdings Stock Overvalued?
Medpace Holdings is trading at a price to free cash flow ratio of 26.60 -
Is Medpace Holdings Stock Undervalued?
Medpace Holdings EV to Free Cash Flow ratio is 25.06 -
What Is Medpace Holdings’s Price Earnings Growth Ratio?
MEDP PEG ratio is 1.67 -
Is Medpace Holdings Trading At A Premium To Earnings?
Medpace Holdings EV to EBIT ratio is 33.50
Is It Risky To Buy Medpace Holdings?
-
How Much Debt Does Medpace Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Medpace Holdings Have?
Cash and short term investments quarterly total is $407M -
What Is Medpace Holdings’s Book Value Per Share?
Book value per share is 21.67
Is Medpace Holdings Cash Flow Positive?
-
What Is MEDP Cash Flow From Operations?
Cash flow from operations (TTM) is $506M -
What Is Medpace Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$122.3M -
What Is Medpace Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$22.6M
Medpace Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
MEDP return on invested capital is 59.87% -
What Is Medpace Holdings Return On Assets?
ROA measures how assets are converting to revenues and is 20.18% -
What Is MEDP Return On Equity?
ROE is a measure of profitability and is 64.05%
Medpace Holdings Earnings Date & Stock Price
-
What Is Medpace Holdings's Stock Price Today?
A single share of MEDP can be purchased today for 395.93 -
What Is Medpace Holdings’s Stock Symbol?
Medpace Holdings trades on the nasdaq under the ticker symbol: MEDP -
When Is Medpace Holdings’s Next Earnings Date?
The next quarterly earnings date for Medpace Holdings is scheduled on July 24, 2024 -
When Is MEDP's next ex-dividend date?
Medpace Holdings's next ex-dividend date is April 28, 2024 -
How To Buy Medpace Holdings Stock?
You can buy Medpace Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Medpace Holdings Competitors
-
Who Are Medpace Holdings's Competitors?
Below is a list of companies who compete with Medpace Holdings or are related in some way:
Medpace Holdings Dividend Yield
Data Unavailable
Medpace Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 40.97% | 29.16% |
Revenue: | 17.73% | -0.19% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 1 |
Price Target: | 418.90 |
Upside from Last Price: | 5.8% |